| Autor: |
Mortato, Edoardo, Baratta, Silvia, Rubino, Luca, De Caro, Anna Paola, Loconsole, Francesco |
| Předmět: |
|
| Zdroj: |
Dermatology Reports; 2024, Vol. 16 Issue 1, p49-50, 2p |
| Abstrakt: |
This article, published in Dermatology Reports, compares the cost of conventional and biological systemic therapies for the management of moderate-to-severe psoriasis. Psoriasis is a chronic inflammatory skin disease that affects both adults and children. The available treatments for moderate-to-severe psoriasis include conventional systemic drugs and systemic biological drugs. The study conducted a cost estimation and found that TNF-α biosimilar inhibitors were more cost-effective compared to conventional DMARDs, despite being among the first-line therapies. However, the study acknowledges the limitations of the small sample size and lack of randomization, suggesting the need for larger prospective studies to validate the results. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
